Prediction of Local Infectious and Inflammatory Complications After Reconstructive Surgery of Aorta

Aim. To identify biomarkers for prediction and early diagnosis of infectious and inflammatory complications in patients after aortic surgery.

Materials and methods. The study included 57 patients who underwent surgical procedures on the aorta and its branches under cardiopulmonary bypass and myocardial ischemia. The cohort was divided into two groups: patients with an uneventful postoperative period (group 1, N=35) and patients with local infectious and inflammatory complications after surgery (group 2, N=22). Serum levels of procalcitonin (PCT), interleukins (IL-6 and IL-10), and aromatic microbial metabolites (AMM) were measured before surgery, upon admission, and six hours after admission to the ICU. On postoperative days 3 and 6 neutrophil, lymphocyte, and platelet counts were assessed, and neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were calculated.

Results. There were no significant differences in sex, age, or comorbidities between groups 1 and 2. Patients in group 2 had a more severe intraoperative period and required a longer ICU stay. Predictive markers of complications included IL-6143.35 pg/mL at ICU admission (sensitivity 42.9%, specificity 90.9%, AUC 0.789, 95% CI 0.669–0.909, P0.001); PCT0.12 ng/mL 6 hours after ICU admission (sensitivity 90.9%, specificity 54.3%, AUC 0.762, 95% CI 0.634–0.891, P0. 001); NLR 7.8 on postoperative day 3 (sensitivity 72.7%, specificity 68.6%, AUC 0.710, 95% CI 0.571–0.850, P=0.003); and AMM (before and after surgery) 0.185 (sensitivity 77.3%, specificity 71.4%, AUC 0.780, 95% CI 0.651–0.909, P0.001).

Conclusion. Values of IL-6, PCT, NLR, and AMM reflect different features of the inflammation and can be used for prediction and early diagnosis of infectious and inflammatory complications in cardiac surgery patients.

1. Popov D. A. Postoperative infectious complications in cardiac surgery. Annals of Surgery = Annaly Khirurgii. 2013; (5): 15–21. (in Russ.).

2. Robich M. P., Sabik J. F. 3rd Houghtaling P. L., Kelava M., Gordon S., Blackstone E. H., Koch C. G. Prolonged effect of postoperative infectious complications on survival after cardiac surgery. Ann Thorac Surg. 2015; 99 (5): 1591–1599. DOI: 10.1016/j.athoracsur.2014.12.037. PMID: 25686669.

3. Jenney A. W., Harrington G. A., Russo P. L., Spelman D. W. Cost of surgical site infections following coronary artery bypass surgery. ANZ J Surg. 2001; 71 (11): 662–664. DOI: 10.1046/j.1445-1433.2001.02225.x. PMID: 11736828.

4. Jonkers D., Elenbaas T., Terporten P., Nieman F., Stobberingh E. Prevalence of 90-days postoperative wound infections after cardiac surgery. Eur J Cardiothorac Surg. 2003; 23 (1): 97–102. DOI: 10.1016/s1010-7940(02)00662-0. PMID: 12493512.

5. Aljure O. D., Fabbro M. 2nd Cardiopulmonary bypass and inflammation: the hidden enemy. J Cardiothorac Vasc Anesth. 2019; 33 (2): 346–347. DOI: 10.1053/j.jvca.2018.05.030. PMID: 30057250.

6. Paparella D., Yau T. M., Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002; 21 (2): 232–244. DOI: 10.1016/s1010-7940(01)01099-5. PMID: 11825729.

7. Maisat W., Yuki K. Narrative review of systemic inflammatory response mechanisms in cardiac surgery and immunomodulatory role of anesthetic agents. Ann Card Anaesth. 2023; 26 (2): 133–142. DOI: 10.4103/aca.aca_147_22. PMID: 37706376.

8. Kraft F., Schmidt C., Van Aken H., Zarbock A. Inflammatory response and extracorporeal circulation. Best Pract Res Clin Anaesthesiol. 2015; 29 (2): 113–123. DOI: 10.1016/j.bpa.2015.03.001. PMID: 26060024.

9. Jayakumar S., Khoynezhad A., Jahangiri M. Surgical site infections in cardiac surgery. Crit Care Clin. 2020; 36 (4): 581–592. DOI: 10.1016/j.ccc.2020.06.006. PMID: 32892815.

10. Michalopoulos A., Geroulanos S., Rosmarakis E. S., Falagas M. E. Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg. 2006; 29 (4): 456–460. DOI: 10.1016/j.ejcts.2005.12.035. PMID: 16481186.

11. Kollef M. H., Sharpless L., Vlasnik J., Pasque C., Murphy D., Fraser V. J. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997; 112 (3): 666–675. DOI: 10.1378/chest.112.3.666. PMID: 9315799.

12. Damavandi D. S., Javan M., Moshashaei H., Forootan M., Darvishi M. Microbial contamination after cardiac surgery in a hospital cardiac surgery ward. J Med Life. 2020; 13 (3): 342–348. DOI: 10.25122/jml-2019-0071. PMID: 33072206.

13. Orita H., Shimanuki T., Fukasawa M., Inui K., Goto S., Washio M., Horikawa H. A clinical study of postoperative infections following open-heart surgery: occurrence and microbiological findings in 782 cases. Surg Today. 1992; 22 (3): 207–212. DOI: 10.1007/BF00308824. PMID: 1392323.

14. Paternoster G., Guarracino F. Sepsis after cardiac surgery: from pathophysiology to management. J Cardiothorac Vasc Anesth. 2016; 30 (3): 773–780. DOI: 10.1053/j.jvca.2015.11.009. PMID: 26947713.

15. Grin O. O., Babaev M. A., Grekova M. S., Kotelnikova E. O., Isalova K. M., Eremenko A. A. Predictive significance of hematological indices in aortic reconstructive surgery: a prospective observational study. Ann Crit Care = Vestnik Intensivnoy Terapii im AI Saltanova. 2024; 1: 82–93. (in Russ.). DOI: 10.21320/1818 474X 2024 1 82 9.

16. Nosocomial pneumonia in adults: Russian national recommendations. Ed. acad. RAS B. R. Gelfand; ed. Candidate of Medical Sciences, Associate Professor D. N. Protsenko, Candidate of Medical Sciences, Associate Professor B. Z. Belotserkovsky. — 2nd ed., revised and exp. M.: Publishing House «Medical Information Agency» LLC; 2016: 176. ISBN 978-5-9986-0284-9.

17. Smid J., Scherner M., Wolfram O., Groscheck T., Wippermann J., Braun-Dullaeus R. C. Cardiogenic causes of fever. Dtsch Arztebl Int. 2018; 115 (12): 193–199. DOI: 10.3238/arztebl.2018.0193. PMID: 29642989.

18. Garibaldi R. A., Brodine S., Matsumiya S., Coleman M. Evidence for the non-infectious etiology of early postoperative fever. Infect Control. 1985; 6 (7): 273–277. DOI: 10.1017/s0195941700061749. PMID: 3847403.

19. Livelli F. D. Jr., Johnson R. A., McEnany M.T., Sherman E., Newell J., Block P. C., DeSanctis R. W. Unexplained in-hospital fever following cardiac surgery. Natural history, relationship to postpericardiotomy syndrome, and a prospective study of therapy with indomethacin versus placebo. Circulation. 1978; 57 (5): 968–975. DOI: 10.1161/01.cir.57.5.968. PMID: 346257.

20. Rhee C., Sax P. E. Evaluation of fever and infections in cardiac surgery patients. 2015; 19 (2): 143–153. DOI: 10.1177/1089253214538524. PMID: 24958717.

21. Bateman R. M., Sharpe M. D., Jagger J. E., Ellis C. G., SolleVolan J., Lopez-Rodrigez M., Herrera-Ramos E., et al. 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016. Crit Care. 2016; 20 (Suppl 2): 94. DOI: 10.1186/s13054-016-1208-6. PMID: 27885969.

22. Verkkala K., Valtonen V., Järvinen A., Tolppanen E. M. Fever, leucocytosis and C-reactive protein after open-heart surgery and their value in the diagnosis of postoperative infections. Thorac Cardiovasc Surg. 1987; 35 (2): 78–82. DOI: 10.1055/s-2007-1020201. PMID: 2440139.

23. Smith S. E., Muir J., Kalabalik-Hoganson J. Procalcitonin in special patient populations: guidance for antimicrobial therapy. Am J Health Syst Pharm. 2020; 77 (10): 745–758. DOI: 10.1093/ajhp/zxaa089. PMID: 32340027.

24. Sharma P., Patel K., Baria K., Lakhia K., Malhotra A., Shah K., Patel S. Procalcitonin level for prediction of postoperative infection in cardiac surgery. Asian Cardiovasc Thorac Ann. 2016; 24 (4): 344–349. DOI: 10.1177/0218492316640953. PMID: 27002098.

25. de la Varga-Martínez O., Martín-Fernández M., Heredia-Rodríguez M., Ceballos F., Cubero-Gallego H., PriedeVimbela J. M., Bardají-Carrillo M., et al. Influence of renal dysfunction on the differential behaviour of procalcitonin for the diagnosis of postoperative infection in cardiac surgery. J Clin Med. 2022; 11 (24): 7274. DOI: 10.3390/jcm11247274. PMID: 36555891.

26. Xie M., Chen Y. T., Zhang H., Zhang H. T., Pan K., Chen X. F., Xie X. L. Diagnostic value of procalcitonin and interleukin6 on early postoperative pneumonia after adult cardiac surgery: a prospective observational study. Heart Surg Forum. 2022; 25 (1): E020–E029. DOI: 10.1532/hsf.4297. PMID: 35238309.

27. Sander M., von Heymann C., von Dossow V., Spaethe C., Konertz W. F., Jain U., Spies C. D. Increased interleukin-6 after cardiac surgery predicts infection. Anesth Analg. 2006; 102 (6): 1623–1629. DOI: 10.1213/01.ane.0000215998.21739.48. PMID: 16717298.

28. Cremer J., Martin M., Redl H., Bahrami S., Abraham C., Graeter T., Haverich A., et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996; 61 (6): 1714–1720. DOI: 10.1016/0003-4975(96)00055-0. PMID: 8651772.

29. Черневская Е. А., Гецина М. Л., Черпаков Р. А., Сорокина Е. А., Шабанов А. К., Мороз В. В., Белобородова Н. В. Сепсис-ассоциированные метаболиты и их биотрансформация кишечной микробиотой. Общая реаниматология. 2023; 19 (6): 4–12. Chernevskaya E. A., Getsina M. L., Cherpakov R. A., Sorokina E. A., Shabanov A. K., Moroz V. V., Beloborodova N. V. Sepsis-associated metabolites and their biotransformation by intestinal microbiota. General Reanimatology = Obshchaya Reanimatologiya. 2023; 19 (6): 4–12. (in Russ.&Eng.). DOI: 10.15360/1813-9779-2023-6-4-12.

30. Beloborodova N., Pautova A., Grekova M., Yadgarov M., Grin O., Eremenko A., Babaev M. Microbiota metabolism failure as a risk factor for postoperative complications after aortic prosthetics. Biomedicines. 2023; 11 (5): 1335. DOI: 10.3390/biomedicines11051335. PMID: 37239006.

31. Nguyen M., Stiel L., Guilloteau A., Bahr P. A., Masson D., Thomas C., Blot M., et al. Leukocyte cell population data in patients with cardiac surgery and cardiopulmonary bypass: a potential readily available tool to monitor immunity. Front Immunol. 2023; 13: 1101937. DOI: 10.3389/fimmu.2022.1101937. PMID: 36741408.

32. Gibson P. H., Croal B. L., Cuthbertson B. H., Small G. R., Ifezulike A. I., Gibson G., Jeffrey R. R., et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J. 2007; 154 (5): 995–1002. DOI: 10.1016/j.ahj.2007.06.043. PMID: 17967611.

33. King A. H., Schmaier A. H., Harth K. C., Kumins N. H., Wong V. L., Zidar D. A., Kashyap V. S., et al. Elevated neutrophillymphocyte ratio predicts mortality following elective endovascular aneurysm repair. J Vasc Surg. 2020; 72 (1): 129–137. DOI: 10.1016/j.jvs.2019.10.058. PMID: 32037083.

34. Khalil C., Pham M., Sawant A. C., Sinibaldi E., Bhardwaj A., Ramanan T., Qureshi R., et al. Neutrophil-to-lymphocyte ratio predicts heart failure readmissions and outcomes in patients undergoing transcatheter aortic valve replacement. Indian Heart J. 2018; 70 Suppl 3 (Suppl 3): S313-S318. DOI: 10.1016/j.ihj.2018.08.002. PMID: 30595282.

35. Zhu Y., Peng W., Zhen S., Jiang X. Postoperative neutrophilto-lymphocyte ratio is associated with mortality in adult patients after cardiopulmonary bypass surgery: a cohort study. Med Sci Monit. 2021; 27: e932954. DOI: 10.12659/MSM.932954. PMID: 34565791.